Literature DB >> 19887408

Fighting HIV/AIDS in Washington, D.C.

Alan E Greenberg1, Shannon L Hader, Henry Masur, A Toni Young, Jennifer Skillicorn, Carl W Dieffenbach.   

Abstract

Washington, D.C., is the capital of the United States and is a major center for public health and health policy expertise. Yet the District of Columbia has an HIV prevalence rate among adults of 3 percent, on par with some sub-Saharan African countries. To date, the local public health response has not controlled the epidemic. The ways in which that response has been galvanized in recent years--through collaboration among the capital's public health agencies, community and faith organizations, and research institutions--may be instructive to other jurisdictions combating HIV/AIDS.

Entities:  

Mesh:

Year:  2009        PMID: 19887408     DOI: 10.1377/hlthaff.28.6.1677

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  39 in total

1.  Making Longitudinal Progress in the HIV Care Continuum Within an Urban Veterans Affairs Clinic.

Authors:  Alicia M Lagasca; Virginia L Kan
Journal:  AIDS Patient Care STDS       Date:  2015-09-08       Impact factor: 5.078

2.  The Best of Both Worlds: Collaborations Can Improve Epidemiological Analyses of Public Health Data.

Authors:  Catherine R Lesko; Jonathan V Todd
Journal:  Sex Transm Dis       Date:  2016-01       Impact factor: 2.830

3.  Critical Review: Building on the HIV Cascade: A Complementary "HIV States and Transitions" Framework for Describing HIV Diagnosis, Care, and Treatment at the Population Level.

Authors:  Kimberly A Powers; William C Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

4.  Longitudinal HIV Care Trajectories in North Carolina.

Authors:  Kimberly A Powers; Erika Samoff; Mark A Weaver; Lynne A Sampson; William C Miller; Peter A Leone; Heidi Swygard
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

5.  The HIV care cascade: simple concept, complex realization.

Authors:  William C Miller; Catherine R Lesko; Kimberly A Powers
Journal:  Sex Transm Dis       Date:  2014-01       Impact factor: 2.830

6.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.

Authors:  Michael J Mugavero; Andrew O Westfall; Stephen R Cole; Elvin H Geng; Heidi M Crane; Mari M Kitahata; W Christopher Mathews; Sonia Napravnik; Joseph J Eron; Richard D Moore; Jeanne C Keruly; Kenneth H Mayer; Thomas P Giordano; James L Raper
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

8.  Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.

Authors:  Catherine R Lesko; Weiqun Tong; Richard D Moore; Bryan Lau
Journal:  AIDS Behav       Date:  2017-04

9.  The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi.

Authors:  Kathryn E Lancaster; Thandie Lungu; Pearson Mmodzi; Mina C Hosseinipour; Katy Chadwick; Kimberly A Powers; Brian W Pence; Vivian F Go; Irving F Hoffman; William C Miller
Journal:  AIDS Care       Date:  2016-07-21

10.  Measuring the HIV Care Continuum Using Public Health Surveillance Data in the United States.

Authors:  Catherine R Lesko; Lynne A Sampson; William C Miller; Jacquelyn Clymore; Peter A Leone; Heidi Swygard; Kimberly A Powers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.